SH
₹82.22
+0.02(+0.02%)
SHUKRAPHAR₹82.22+0.02%
Group Companies
Foreign Flows
sector level — not this stockHealthcare sector−₹5,497 Crnet foreign selling
2026-10-01 to 2026-10-15This is the flow into the whole Healthcare sector, not into SHUKRAPHAR. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.
Supply Chain
suppliers and customers in the graphMacro Sensitivity
rates, currency, commoditiesRevenue by Segment
Business Group
Geographic Exposure
revenue, imports, currencyScenario analysis
stated assumptions, shown workingsSHUKRAPHAR exposure summary
In its latest segment disclosure (Sep 2026), Pharamaceutical segment was the largest segment at 72.1% of segment revenue, followed by Medtech segment at 27.9%. Shukra Medtech Ltd is a constituent of 2 indices.
| Index memberships | 2 |
|---|---|
| Largest segment | Pharamaceutical segment · 72.1% |